1. Home
  2. BC vs RYTM Comparison

BC vs RYTM Comparison

Compare BC & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brunswick Corporation

BC

Brunswick Corporation

HOLD

Current Price

$86.92

Market Cap

5.4B

ML Signal

HOLD

Logo Rhythm Pharmaceuticals Inc.

RYTM

Rhythm Pharmaceuticals Inc.

HOLD

Current Price

$109.87

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BC
RYTM
Founded
1845
2008
Country
United States
United States
Employees
14000
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
5.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
BC
RYTM
Price
$86.92
$109.87
Analyst Decision
Buy
Strong Buy
Analyst Count
11
14
Target Price
$83.55
$131.14
AVG Volume (30 Days)
589.2K
814.7K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
2.22%
N/A
EPS Growth
N/A
28.34
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.81
$55.34
Revenue Next Year
$5.11
$86.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$54.73
$62.29
52 Week High
$90.25
$122.20

Technical Indicators

Market Signals
Indicator
BC
RYTM
Relative Strength Index (RSI) 58.83 72.82
Support Level $84.13 $98.30
Resistance Level $89.67 $113.03
Average True Range (ATR) 2.85 5.09
MACD 0.42 2.15
Stochastic Oscillator 75.89 82.64

Price Performance

Historical Comparison
BC
RYTM

About BC Brunswick Corporation

Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns more than 450 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Share on Social Networks: